BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 36164556)

  • 1. Successful Treatment of a Patient with Pyoderma Gangrenosum, Plaque Psoriasis and Palmoplantar Pustulosis with Adalimumab.
    Chu Y; Liu T; Bai J; Fang H; Qiao J
    Clin Cosmet Investig Dermatol; 2022; 15():1991-1995. PubMed ID: 36164556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.
    Ohtsuka M; Yamamoto T
    J Dermatol; 2014 Aug; 41(8):732-5. PubMed ID: 24986043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarity and difference between palmoplantar pustulosis and pustular psoriasis.
    Yamamoto T
    J Dermatol; 2021 Jun; 48(6):750-760. PubMed ID: 33650702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.
    Menter A; Van Voorhees AS; Hsu S
    Dermatol Ther (Heidelb); 2021 Dec; 11(6):1917-1929. PubMed ID: 34626330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum following anti-TNF therapy in chronic recurrent multifocal osteomyelitis: drug reaction or cutaneous manifestation of the disease? A critical review on the topic with an emblematic case report.
    Romagnuolo M; Moltrasio C; Iannone C; Gattinara M; Cambiaghi S; Marzano AV
    Front Med (Lausanne); 2023; 10():1197273. PubMed ID: 37324147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What do we know about palmoplantar pustulosis?
    Misiak-Galazka M; Wolska H; Rudnicka L
    J Eur Acad Dermatol Venereol; 2017 Jan; 31(1):38-44. PubMed ID: 27521275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extra-palmoplantar lesions associated with palmoplantar pustulosis.
    Yamamoto T
    J Eur Acad Dermatol Venereol; 2009 Nov; 23(11):1227-32. PubMed ID: 19453807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biologic therapies associated with development of palmoplantar pustulosis and palmoplantar pustular psoriasis: a systematic review.
    Lu JD; Lytvyn Y; Mufti A; Zaaroura H; Sachdeva M; Kwan S; Abduelmula A; Kim P; Yeung J
    Int J Dermatol; 2023 Jan; 62(1):12-21. PubMed ID: 35128653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Japanese Patients with Palmoplantar Pustulosis.
    Yamamoto T
    Clin Drug Investig; 2019 Mar; 39(3):241-252. PubMed ID: 30632109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Palmoplantar pustulosis: Current understanding of disease definition and pathomechanism.
    Murakami M; Terui T
    J Dermatol Sci; 2020 Apr; 98(1):13-19. PubMed ID: 32201085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Efficacy of Biologic Therapy for the Management of Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review.
    Sanchez IM; Sorenson E; Levin E; Liao W
    Dermatol Ther (Heidelb); 2017 Dec; 7(4):425-446. PubMed ID: 29143230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Photodynamic therapy for palmoplantar pustulosis: A case report.
    Huang J; Wu M; Wang H
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103829. PubMed ID: 37806607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Review of Neutrophilic Diseases.
    Marzano AV; Borghi A; Wallach D; Cugno M
    Clin Rev Allergy Immunol; 2018 Feb; 54(1):114-130. PubMed ID: 28688013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Refractory Palmoplantar Pustulosis Successfully Treated with JAK Inhibitor Tofacitinib: A Case Series.
    Xu Q; Wang X; Yang A; Wei G
    Infect Drug Resist; 2023; 16():5165-5172. PubMed ID: 37581169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A brief guide to pustular psoriasis for primary care providers.
    Crowley JJ; Pariser DM; Yamauchi PS
    Postgrad Med; 2021 Apr; 133(3):330-344. PubMed ID: 33118424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guselkumab for the Treatment of Palmoplantar Pustulosis: A Japanese Perspective.
    Yamamoto T
    Clin Pharmacol; 2021; 13():135-143. PubMed ID: 34188558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review.
    Sawka E; Zhou A; Latour E; Friedman M; Ortega-Loayza AG
    Clin Rheumatol; 2021 Oct; 40(10):3963-3969. PubMed ID: 34002351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
    Andersen YMF; Augustin M; Petersen J; Hagenström K; Mallbris L; Burge R; Egeberg A
    Br J Dermatol; 2019 Nov; 181(5):976-982. PubMed ID: 30815849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What do autoinflammatory syndromes teach about common cutaneous diseases such as pyoderma gangrenosum? A commentary.
    Butler D; Shinkai K
    Dermatol Clin; 2013 Jul; 31(3):427-35. PubMed ID: 23827245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.